Targeting the TGFβ pathway in uterine carcinosarcoma

Uterine carcinosarcoma (UCS) is a relatively infrequent, but extremely aggressive endometrial malignancy. Although surgery and chemotherapy have improved outcomes, overall survival (OS) remains dismal due to the lack of targeted therapy and biphasic (epithelial and mesenchymal) nature that renders t...

Descripción completa

Detalles Bibliográficos
Autores principales: Dwivedi, Shailendra Kumar Dhar, Rao, Geeta, Dey, Anindya, Buechel, Megan, Zhang, Yushan, Zhang, Min, Yang, Da, Mukherjee, Priyabrata, Bhattacharya, Resham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shared Science Publishers OG 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590842/
https://www.ncbi.nlm.nih.gov/pubmed/33150300
http://dx.doi.org/10.15698/cst2020.11.234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590842/
https://www.ncbi.nlm.nih.gov/pubmed/33150300
http://dx.doi.org/10.15698/cst2020.11.234

Ejemplares similares